A 49-year-old cisgender man with HIV and a long history of opioid use disorder is admitted to the hospital for management of a methicillin-resistant Staphylococcus aureus (MRSA) abscess secondary to injection. During the hospital stay, the medical team discusses pharmacologic therapies for treating his opioid use disorder. He is very interested in trying buprenorphine or buprenorphine-naloxone, as one of his close friends quit heroin after going on buprenorphine-naloxone.
For the fixed-dose combination of oral buprenorphine-naloxone that is used as therapy for opioid use disorder, what is the purpose of the naloxone component?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
October 1st, 2023
October 1st, 2023
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5